The stomach's functional capacity may adapt to smaller meal portions over time, but this is reversible if eating patterns change after treatment discontinuation
Understanding the differences between their mechanisms, half-lives, and dosing protocols will determine whether your switch is smooth or rocky
has received honoraria, teaching, and research sponsorship/grants from Abbott, AstraZeneca, Boehringer Ingelheim, Cellnovo, Eli Lilly, Merck Sharp & Dohme, Novo Nordisk, and Sanofi-aventis, Cardiff University, Doctors.net, Elsevier, Onmedica, Omnia-Med, Medscape, All-Wales Medicines Strategy Group, National Institute for Health and Care Excellence (NICE) UK, and Glycosmedia
Switching from semaglutide to retatrutide will be the second-most-common path